Level of biochemical parameters in patients with type 2 diabetes mellitus depending on the genotype of the FokI polymorphism in the vitamin D3 receptor (VDR gene)
Language English Country Czech Republic Media print
Document type Journal Article
PubMed
38272481
DOI
10.21101/cejph.a7837
Knihovny.cz E-resources
- Keywords
- HDL, SNP FokI, T2DM, glucose, vitamin D receptor,
- MeSH
- Cholesterol MeSH
- Diabetes Mellitus, Type 2 * complications MeSH
- Genetic Predisposition to Disease MeSH
- Genotype MeSH
- Glucose MeSH
- Polymorphism, Single Nucleotide MeSH
- Humans MeSH
- Receptors, Calcitriol * genetics metabolism MeSH
- Aged MeSH
- Case-Control Studies MeSH
- Check Tag
- Humans MeSH
- Aged MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Cholesterol MeSH
- Glucose MeSH
- Receptors, Calcitriol * MeSH
- VDR protein, human MeSH Browser
OBJECTIVES: Diabetes mellitus type 2 (T2DM) is a multifactorial and polygenic disorder characterised by chronic hyperglycaemia accompanied by impaired lipid, carbohydrate, and protein metabolism. The disease is associated with several genetic polymorphisms, including the FokI polymorphism in the vitamin D receptor (VDR) gene. METHODS: We conducted a study of 327 probands (191 T2DM patients, 136 controls), with a mean age 65.06 (SD ± 10.88) years of patients with T2DM and 58.89 (SD ± 6.59) years in the healthy probands. We investigated the association between FokI polymorphism and biochemical parameters in T2DM patients in the Slovak population. Anthropometric measurements, biochemical, and genetic analysis were statistically evaluated by Statistica ver.13 software using t-tests. RESULTS: Biochemical analysis confirmed significantly higher mean values of total cholesterol (TC), triglyceride (TG), glucose (GLU), and uric acid (UA) (p < 0.001) in T2DM probands and statistically significantly lower values of high-density lipoprotein (HDL), cholesterol and vitamin D (p < 0.001). Allele frequencies and genotype distributions of the FokI (rs2228570) polymorphism were not significantly different between T2DM patients and controls (p = 0.909). Patients with T2DM and TT genotype had the highest glucose level of 11.39 (SD ± 2.32) uU/ml (p < 0.001). CONCLUSION: Our study did not provide evidence for an association of the investigated FokI polymorphism of the VDR gene with T2DM in the Slovak population. Further research is needed to evaluate the impact of single nucleotide polymorphisms (SNPs) in the VDR gene, focusing on related genetic analyses in a larger T2DM cohort.
See more in PubMed
Bid HK, Konwar R, Aggarwal CG, Gautam S, Saxena M, Nayak VL, et al. Vitamin D receptor (FokI, BsmI and TaqI) gene polymorphisms and type 2 diabetes mellitus: a North Indian study. Indian J Med Sci. 2009;63(5):187-94. DOI
DeFronzo RA. Pathogenesis of type 2 diabetes mellitus. Med Clin North Am. 2004;88(4):787-835. DOI
Krauss RM. Lipids and lipoproteins in patients with type 2 diabetes. Diabetes Care. 2004;27(6):1496-504. DOI
Hatmal MM, Abderrahman SM, Nimer W, Al-Eisawi Z, Al-Ameer HJ, Al-Hatamleh MAI, et al. Artificial neural networks model for predicting type 2 diabetes mellitus based on VDR gene FokI polymorphism, lipid profile and demographic data. Biology. 2020;13;9(8):222. doi: 10.3390/biology9080222. PubMed DOI
Dou Z, Xia Y, Zhang J, Li Y, Zhang Y, Zhao L, et al. Syndrome differentiation and treatment regularity in traditional Chinese medicine for type 2 diabetes: a text mining analysis. Front Endocrinol. 2021;12:728032. doi: 10.3389/fendo.2021.728032. PubMed DOI
Eizirik DL, Colli ML, Ortis F. The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat Rev Endocrinol. 2009;5(4):219-26. DOI
Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, et al.; Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911-30. DOI
Melamed ML, Michos ED, Post W, Astor B. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med. 2008;168:629-37. DOI
Filus A, Trzmiel A, Kuliczkowska-Płaksej J, Tworowska U, Jedrzejuk D, Milewicz A, et al. Relationship between vitamin D receptor BsmI and FokI polymorphisms and anthropometric and biochemical parameters describing metabolic syndrome. Aging Male. 2008;11(3):134-9. DOI
Alfaqih MA, Araidah A, Amarin Z, Saadeh R, Al-Shboul O, Khanfar M, et al. Association of vitamin D levels and polymorphisms in vitamin D receptor with type 2 diabetes mellitus. Biomed Rep. 2022;18(1):3. doi: 10.3892/br.2022.1585. PubMed DOI
Gendy HIE, Sadik NA, Helmy MY, Rashed LA. Vitamin D receptor gene polymorphisms and 25(OH) vitamin D: lack of association to glycemic control and metabolic parameters in type 2 diabetic Egyptian patients. J Clin Transl Endocrinol. 2018;15:25-9. DOI
Jurutka PW, Remus LS, Whitfield GK, Thompson PD, Hsieh JC, Zitzer H, et al. The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB. Mol Endocrinol. 2000;14(3):401-20. DOI
Uitterlinden AG, Fang Y, Van Meurs JB, Pols HA, Van Leeuwen JP. Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004;338(2):143-56. DOI
Tangestani H, Shab-Bidar S. Association between FokI Vitamin D receptor gene polymorphism and visceral obesity in patients with type 2 diabetes: a single-blinded randomised clinical trial. J Nutr Sci Diet. 2018;4(4):132-8.
Wang Q, Xi B, Reilly KH, Liu M, Fu M. Quantitative assessment of the associations between four polymorphisms (FokI. ApaI. BsmI. TaqI) of vitamin D receptor gene and risk of diabetes mellitus. Mol Biol Rep. 2012;39:9405-14. DOI
Christakos S, Dhawan P, Verstuyf A, Verlinden L, Carmeliet G. Vitamin D: metabolism, molecular mechanism of action, and pleiotropic effects. Physiol Rev. 2016;96:365-408. DOI
Piña-Aguero MI, Maldonado-Hernández J, Sebastián-Medina L, Tejero-Barrera ME, Robledo-Pérez RM, Villalpando-Hernández S. Relationship between VDR gene polymorphisms, beta-cell function, and vitamin D status in non-obese Mexican adults: a cross-sectional study. Arch Med Res. 2022;53(4):416-22. DOI
Angel B, Lera L, Márquez C, Albala C. The association of VDR polymorphisms and type 2 diabetes in older people living in a community in Santiago de Chile. Nutr Diabetes. 2018;8(1):31. doi: 10.1038/s41387-018-0038-9. PubMed DOI
Divanogloua N, Komninoua D, Steab EA, Argirioub A, Papatzikasc G, Tsakalofd A, et al. Association of Vitamin D receptor gene polymorphisms with serum Vitamin D levels in a Greek rural population (Velestino Study). Lifestyle Genomics. 2021;14:81-90. DOI
Mahjoubi I, Kallel A, Sbaï MH, Ftouhi B, Ben Halima M, Jemaa Z, et al. Lack of association between FokI polymorphism in vitamin D receptor gene (VDR) & type 2 diabetes mellitus in the Tunisian population. Indian J Med Res. 2016;144(1):46-51. DOI
Al-Darraji SZ, Al-Azzawie HF, Al-Kharsani AR. Vitamin D Status and its receptor genes BsmI. FokI. ApaI. TaqI polymorphism in relation to glucose metabolism in obese Iraqi type 2 diabetes mellitus patients. J Mol Genet Med. 2017;11:260. DOI
Mackawy AMH; Badawi MEH. Association of vitamin D and vitamin D receptor gene polymorphisms with chronic inflammation, insulin resistance and metabolic syndrome components in type 2 diabetic Egyptian patients. Meta Gene. 2014;2:540-56. DOI
Malecki MT. Frey J, Moczulski D, Klupa T, Kozek E, Sieradzki J. Vitamin D receptor gene polymorphisms and association with type 2 diabetes mellitus in a Polish population. Exp Clin Endocrinol Diabetes. 2003;111:505-9. DOI
Rawoof AM, Promela M, Arif AB, SheikhIshaq, Rabia F. Vitamin D Receptor (VDR) gene polymorphism and type 2 Diabetic Mellitus (T2DM) - a case control study in ethnic population of Kashmir Valley. Adv Res Gastroentero Hepatol. 2017;4(5):555648. DOI
Safar HA, Chehadeh SEH, Abdel-Wareth L, Haq A, Jelinek HF, ElGhazali G, et al. Vitamin D receptor gene polymorphisms among Emirati patients with type 2 diabetes mellitus. J Steroid Biochem Mol Biol. 2018;175:119-24. DOI
Schuch NJ, Garcia VC, Vívolo SRGF, Martini LA. Relationship between vitamin D receptor gene polymorphisms and the components of metabolic syndrome. Nutr J. 2013;12(1):1-7. DOI
Li L, Bo W, Ji-Yong L, Li-Bo Y. Vitamin D receptor gene polymorphisms and type 2 diabetes: a meta-analysis. Arch Med Res. 2013;4:235-41. DOI
Liu Y, Guo X, Huang SY, Gong L, Cui JH, Shen HW, et al. Evaluation of association studies and a systematic review and meta-analysis of VDR polymorphisms in type 2 diabetes mellitus risk. Medicine (Baltimore). 2021;16;100(28):e25934. doi: 10.1097/MD.0000000000025934. PubMed DOI